Document is current

Any future updates will be listed below

Initial safety report on the tolerability of modified FOLFOX6 as adjuvant therapy in patients with curatively resected stage II or III colon cancer (JFMC41-1001-C2: JOIN trial)

Crossref DOI link: https://doi.org/10.1007/s00280-015-2757-0

Published Online: 2015-05-16

Published Print: 2015-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark